Frazier Life Sciences Management, L.P. Bridge Bio Pharma, Inc. Transaction History
Frazier Life Sciences Management, L.P.
- $1.59 Billion
- Q1 2025
A detailed history of Frazier Life Sciences Management, L.P. transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Frazier Life Sciences Management, L.P. holds 3,800,457 shares of BBIO stock, worth $187 Million. This represents 8.27% of its overall portfolio holdings.
Number of Shares
3,800,457
Previous 3,800,457
-0.0%
Holding current value
$187 Million
Previous $104 Million
25.98%
% of portfolio
8.27%
Previous 6.25%
Shares
7 transactions
Others Institutions Holding BBIO
# of Institutions
392Shares Held
187MCall Options Held
12.7MPut Options Held
2.28M-
Viking Global Investors LP22.1MShares$1.08 Billion2.55% of portfolio
-
Kohlberg Kravis Roberts & Co. L.P. New York, NY19.3MShares$946 Million30.7% of portfolio
-
Vanguard Group Inc Valley Forge, PA16.5MShares$809 Million0.01% of portfolio
-
Black Rock Inc. New York, NY12.4MShares$611 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X07.17MShares$352 Million0.14% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $7.28B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...